
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 28, 2024, titled "Emcure Pharma Strengthens its Derma Portfolio with the launch of Emcutix Biopharmaceuticals Limited".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 28, 2024, titled "Emcure Pharma Strengthens its Derma Portfolio with the launch of Emcutix Biopharmaceuticals Limited".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals